ATE80303T1 - Fluessigkeitstherapie mit 1-laktat- und/oder pyruvat-anionen. - Google Patents

Fluessigkeitstherapie mit 1-laktat- und/oder pyruvat-anionen.

Info

Publication number: ATE80303T1
Authority: AT; Austria
Prior art keywords: lactate; fluid therapy; pyruvate; anions; pyruvate anions
Prior art date: 1985-12-18

Application number

AT86309899T

Other languages

English (en)

Inventor

Richard L Veech

Original Assignee

Richard L Veech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-12-18

Filing date

1986-12-18

Publication date

1992-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25205036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE80303(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1986-12-18 Application filed by Richard L Veech filed Critical Richard L Veech

1992-09-15 Application granted granted Critical

1992-09-15 Publication of ATE80303T1 publication Critical patent/ATE80303T1/de

Links

239000012530 fluid Substances 0.000 title abstract 3
-1 PYRUVATE ANIONS Chemical class 0.000 title abstract 2
238000002560 therapeutic procedure Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 abstract 3
229940116871 l-lactate Drugs 0.000 abstract 2
WHBMMWSBFZVSSR-GSVOUGTGSA-M (R)-3-hydroxybutyrate Chemical compound C[C@@H](O)CC([O-])=O WHBMMWSBFZVSSR-GSVOUGTGSA-M 0.000 abstract 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 abstract 1
WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 abstract 1
230000002411 adverse Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
231100000331 toxic Toxicity 0.000 abstract 1
230000002588 toxic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Emergency Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Inorganic Chemistry (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
External Artificial Organs (AREA)

AT86309899T 1985-12-18 1986-12-18 Fluessigkeitstherapie mit 1-laktat- und/oder pyruvat-anionen. ATE80303T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US81091885A	1985-12-18	1985-12-18
EP86309899A EP0249667B2 (de)	1985-12-18	1986-12-18	Flüssigkeitstherapie mit 1-Laktat- und/oder Pyruvat-Anionen

Publications (1)

Publication Number	Publication Date
ATE80303T1 true ATE80303T1 (de)	1992-09-15

Family

ID=25205036

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86309899T ATE80303T1 (de)	1985-12-18	1986-12-18	Fluessigkeitstherapie mit 1-laktat- und/oder pyruvat-anionen.

Country Status (11)

Country	Link
US (1)	US5100677A (de)
EP (1)	EP0249667B2 (de)
JP (1)	JPS63502274A (de)
CN (1)	CN86108978A (de)
AT (1)	ATE80303T1 (de)
AU (4)	AU6776887A (de)
DE (1)	DE3686718T3 (de)
ES (1)	ES2052495T5 (de)
GR (1)	GR3006492T3 (de)
IL (1)	IL81030A0 (de)
WO (1)	WO1987003808A1 (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6020007A (en) *	1984-06-22	2000-02-01	Btg International Limited	Fluid therapy with l-lactate and/or pyruvate anions
USRE38604E1 (en) *	1984-06-22	2004-09-28	Btg International Limited	Fluid therapy with L-lactate and/or pyruvate anions
US5719119A (en) *	1985-12-18	1998-02-17	British Technology Group, Ltd.	Parenteral nutrition therapy with amino acids
FR2619715A1 (fr) *	1987-08-25	1989-03-03	Bayle Francois	Serum glucose polyionique iso-osmotique
US5310768A (en) *	1987-10-29	1994-05-10	Ab Erik Vinnars	Method for improving the glutamine content in skeletal muscle and composition therefore
BE1001209A3 (fr) *	1987-11-19	1989-08-22	Solvay	Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
US5292774A (en) *	1988-07-26	1994-03-08	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
US5112622A (en) *	1990-01-19	1992-05-12	Kopp Klaus F	Intravenous solutions for influencing renal function and for maintenance therapy
EP0658353A1 (de) *	1993-11-19	1995-06-21	Bertold Dr. Reinhardt	Pyruvathaltige CAPD- und Substitutionslösungen sowie pyruvathaltige Dialysierflüssigkeiten
AU701724B2 (en) *	1994-07-01	1999-02-04	Baxter International Inc.	Biochemically balanced peritoneal dialysis solutions
DE19515554C2 (de) *	1995-04-27	1999-06-17	Braun Melsungen Ag	Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
US6417231B1 (en)	1996-12-23	2002-07-09	Frank L. Greenway	Method and composition for delivering therapeutically effective amounts of pyruvate to a mammal
US6323237B1 (en) *	1997-03-17	2001-11-27	Btg International Limited	Therapeutic compositions
US20090253781A1 (en) *	2002-05-24	2009-10-08	Btg International Limited	Therapeutic compositions
US6316038B1 (en)	1997-03-17	2001-11-13	Btg International Limited	Therapeutic compositions
DE19859771C1 (de) *	1998-12-23	2000-08-24	Sueddeutsche Kalkstickstoff	Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung
US8105258B2 (en)	1999-04-26	2012-01-31	Baxter International Inc.	Citrate anticoagulation system for extracorporeal blood treatments
US7186420B2 (en) *	1999-04-26	2007-03-06	Edwards Lifesciences Corporation	Multi-part substitution infusion fluids and matching anticoagulants
US6309673B1 (en)	1999-09-10	2001-10-30	Baxter International Inc.	Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
US6846842B2 (en) *	1999-10-07	2005-01-25	Beth Israel Deconess Medical Center, Inc.	Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
WO2002081020A2 (en) *	2001-04-04	2002-10-17	Critical Therapeutics, Inc.	Method for preventing acute renal failure
AU2002314847A1 (en)	2001-05-31	2002-12-09	Upsher-Smith Laboratories, Inc.	Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
US7122210B2 (en)	2002-01-11	2006-10-17	Baxter International Inc.	Bicarbonate-based solutions for dialysis therapies
JP2005526832A (ja) *	2002-04-17	2005-09-08	クリティカルセラピューティクス，インコーポレイテッド	α−ケトアルカン酸エステルまたは−アミドおよび乳酸または乳酸塩を含有する医薬組成物
US7445801B2 (en)	2002-06-07	2008-11-04	Baxter International Inc.	Stable bicarbonate-based solution in a single container
IL151169A0 (en) *	2002-08-09	2003-04-10	Talgon Invest Ltd	A peritoneal dialysis solution
US20040121982A1 (en) *	2002-12-20	2004-06-24	Leo Martis	Biocompatible dialysis fluids containing icodextrins
US20080125488A1 (en) *	2003-05-01	2008-05-29	Leverve Xavier M	Lactate Containing Pharmaceutical Composition and Uses Thereof
US7132221B2 (en) *	2003-09-12	2006-11-07	Headway Technologies, Inc.	Method to print photoresist lines with negative sidewalls
ES2246690B1 (es) *	2004-03-30	2007-04-01	Jose Luis Pelluz Garcia	Composicion de plasma sanguineo.
ES2246691B1 (es) *	2004-03-30	2007-04-01	Jose Luis Dieter De Shart, S.L.	Composicion de acido l(+)-lactico de origen natural y organico.
GB0420856D0 (en) *	2004-09-20	2004-10-20	Ketocytonyx Inc	Cns modulators
US20050276868A1 (en) *	2004-06-10	2005-12-15	Bart Degreve	Bicarbonate-based peritoneal dialysis solutions
EP1778213B1 (de)	2004-07-16	2017-04-05	BTG International Limited	Verfahren zur herstellung oligomerer verbindungen
US7485743B2 (en) *	2004-07-20	2009-02-03	Btg International Limited	Oligomeric ketone compounds
US20070225252A1 (en) *	2004-07-23	2007-09-27	Gross Richard A	Ketogenic Saccharides
EP1793813A4 (de) *	2004-09-21	2011-05-18	Btg Int Ltd	Behandlung von adhd
DK1796658T3 (en) *	2004-09-21	2016-06-27	Btg Int Ltd	dopaminergic mimetics
US7935070B2 (en)	2005-01-28	2011-05-03	Fresenius Medical Care North America	Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
BRPI0621528A2 (pt) *	2006-04-03	2011-12-13	Innogene Kalbiotech Pte Ltd	composição farmacêutica contendo lactato e cálcio, e usos da mesma
US8728532B2 (en) *	2007-04-12	2014-05-20	Regents Of The University Of Minnesota	Ischemia/reperfusion protection compositions and methods of using
US7754247B2 (en) *	2007-05-29	2010-07-13	University Of South Carolina	Resuscitation fluid
US20120064178A1 (en) *	2010-09-13	2012-03-15	Carolyn Flora Anne Dean	Cell-8 Solution
US9585810B2 (en)	2010-10-14	2017-03-07	Fresenius Medical Care Holdings, Inc.	Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
US8557301B2 (en) *	2011-07-01	2013-10-15	Drip Drop, Inc.	Oral rehydration composition
US10245243B1 (en)	2017-12-19	2019-04-02	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
US11103470B2 (en)	2017-11-22	2021-08-31	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10292952B2 (en) *	2016-03-11	2019-05-21	Axcess Global Sciences, Llc	Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
US10245242B1 (en)	2017-11-22	2019-04-02	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10973786B2 (en)	2016-03-11	2021-04-13	Axcess Global Sciences, Llc	R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10596129B2 (en)	2017-11-22	2020-03-24	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10596130B2 (en)	2017-12-19	2020-03-24	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
US11241403B2 (en)	2016-03-11	2022-02-08	Axcess Global Sciences, Llc	Beta-hydroxybutyrate mixed salt compositions and methods of use
US10973792B2 (en)	2019-02-13	2021-04-13	Axcess Global Sciences, Llc	Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US10736861B2 (en)	2016-03-11	2020-08-11	Axcess Global Sciences, Llc	Mixed salt compositions for producing elevated and sustained ketosis
US10596131B2 (en)	2017-11-22	2020-03-24	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11185518B2 (en)	2017-12-19	2021-11-30	Axcess Global Sciences, Llc	S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US12521378B2 (en)	2016-04-19	2026-01-13	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans
US10925843B2 (en)	2018-04-18	2021-02-23	Axcess Global Sciences, Llc	Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11944598B2 (en)	2017-12-19	2024-04-02	Axcess Global Sciences, Llc	Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US11202769B2 (en)	2017-11-22	2021-12-21	Axcess Global Sciences, Llc	Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US12533346B2 (en)	2016-04-19	2026-01-27	Axcess Global Sciences, Llc	Administration of berberine metabolites
US12329734B2 (en)	2017-12-19	2025-06-17	Axcess Global Sciences, Llc	Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US12496283B2 (en)	2016-04-19	2025-12-16	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate and related compounds in humans
US12109182B2 (en)	2016-04-19	2024-10-08	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate and related compounds in humans
US11806324B2 (en)	2018-04-18	2023-11-07	Axcess Global Sciences, Llc	Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US20230346721A1 (en)	2018-04-18	2023-11-02	Axcess Global Sciences, Llc	Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies
US10307398B2 (en)	2016-09-20	2019-06-04	Regents Of The University Of Minnesota	Resuscitation composition and methods of making and using
US12090129B2 (en)	2017-11-22	2024-09-17	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10980772B2 (en)	2018-08-27	2021-04-20	Axcess Global Sciences, Llc	Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US11241401B2 (en)	2020-02-06	2022-02-08	Axcess Global Sciences, Llc	Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US11129802B2 (en)	2018-08-27	2021-09-28	Axcess Global Sciences, Llc	Compositions and methods for delivering cannabidiol and ketone bodies
US11419836B2 (en)	2019-02-13	2022-08-23	Axcess Global Sciences, Llc	Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US12472200B2 (en)	2019-05-15	2025-11-18	Axcess Global Sciences, Llc	Autobiotic compositions and method for promoting healthy gut microbiome
US11969430B1 (en)	2023-03-10	2024-04-30	Axcess Global Sciences, Llc	Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11950616B2 (en)	2019-06-21	2024-04-09	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en)	2019-06-21	2024-12-17	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11033553B2 (en)	2019-06-21	2021-06-15	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12186297B2 (en)	2020-08-26	2025-01-07	Axcess Global Sciences, Llc	Compositions and methods for increasing lean-to-fat mass ratio
EP4366718A1 (de) *	2021-07-08	2024-05-15	Institut National de la Santé et de la Recherche Médicale (INSERM)	Neues verfahren zur behandlung von erkrankungen im zusammenhang mit azidose mit acetoacetat
JP2024541652A (ja) *	2021-12-01	2024-11-08	ガンブロ・ルンディア・エービー	新しい透析液
US12440512B1 (en) *	2024-12-08	2025-10-14	Iv Nector Md	Systems and methods for preparing and administering a hydrating supplement composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3993750A (en) *	1974-12-20	1976-11-23	Research Corporation	Aqueous hypertonic solution and compositions useful for preparation of same
US4308255A (en) *	1980-03-24	1981-12-29	Haemophor Corporation	Balanced oncotic pressure fluid
ATE22655T1 (de) *	1982-11-10	1986-10-15	Laevosan Gmbh & Co Kg	Infusionsloesungen zur herztherapie.
IT1214872B (it) †	1984-04-06	1990-01-18	Mariano Feriani	Sacca contenente due o piu'sostanze per infusione ad uso medicale, poste in scomparti separati, comprendente mezzi atti a consentire la miscelazione di tali sostanze solo al momento dell'uso.

1986
- 1986-12-17 US US06/940,333 patent/US5100677A/en not_active Expired - Lifetime
- 1986-12-17 WO PCT/US1986/002689 patent/WO1987003808A1/en not_active Ceased
- 1986-12-17 AU AU67768/87A patent/AU6776887A/en not_active Abandoned
- 1986-12-17 JP JP62500288A patent/JPS63502274A/ja active Pending
- 1986-12-18 DE DE3686718T patent/DE3686718T3/de not_active Expired - Lifetime
- 1986-12-18 EP EP86309899A patent/EP0249667B2/de not_active Expired - Lifetime
- 1986-12-18 IL IL81030A patent/IL81030A0/xx unknown
- 1986-12-18 CN CN86108978A patent/CN86108978A/zh active Pending
- 1986-12-18 AT AT86309899T patent/ATE80303T1/de not_active IP Right Cessation
- 1986-12-18 ES ES86309899T patent/ES2052495T5/es not_active Expired - Lifetime
1990
- 1990-12-28 AU AU68558/90A patent/AU6855890A/en not_active Abandoned
1992
- 1992-12-09 GR GR920402848T patent/GR3006492T3/el unknown
1994
- 1994-04-22 AU AU60669/94A patent/AU6066994A/en not_active Abandoned
1997
- 1997-06-13 AU AU24880/97A patent/AU2488097A/en not_active Abandoned

Also Published As

Publication number	Publication date
IL81030A0 (en)	1987-03-31
AU6066994A (en)	1994-06-23
AU2488097A (en)	1997-08-21
ES2052495T3 (es)	1994-07-16
EP0249667B2 (de)	2004-12-29
WO1987003808A1 (en)	1987-07-02
US5100677A (en)	1992-03-31
EP0249667A1 (de)	1987-12-23
CN86108978A (zh)	1987-11-04
DE3686718T2 (de)	1993-04-22
ES2052495T5 (es)	2005-07-16
DE3686718T3 (de)	2005-11-17
EP0249667B1 (de)	1992-09-09
DE3686718D1 (de)	1992-10-15
AU6776887A (en)	1987-07-15
JPS63502274A (ja)	1988-09-01
AU6855890A (en)	1991-03-14
GR3006492T3 (de)	1993-06-21

Legal Events

Date	Code	Title	Description
1993-07-15	UEP	Publication of translation of european patent specification
1997-09-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE80303T1 (de)	1992-09-15	Fluessigkeitstherapie mit 1-laktat- und/oder pyruvat-anionen.
ATE89819T1 (de)	1993-06-15	Gegebenenfalls alpha-substituierte 4-(chinolin-2- yl-methoxy)phenylessigsaeuren und -ester.
SE8402560L (sv)	1984-11-14	Farmaceutisk komposition
DE19375061I2 (de)	2008-11-20	Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
FI925549A0 (fi)	1992-12-07	Nya azaheterocyklylmetyl-kromaner
ES2127965T3 (es)	1999-05-01	Derivados de acidos benzofuranil- y benzotiofenil-alcanocarboxilicos heterociclilcarbonil sustituidos.
ES2032376T3 (es)	1993-02-16	Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
AU633603B2 (en)	1993-02-04	Pharmaceutical compositions
ATE164159T1 (de)	1998-04-15	Substituierte triole
NL193217B (nl)	1998-11-02	1-Methyl-5-p-toluoyl-2-pyrroolaceetamidederivaat met ontstekingsremmende en analgetische eigenschappen en farmaceutisch preparaat dat het bevat.
NL193440B (nl)	1999-07-01	Farmaceutisch preparaat met analgetische werking.
EP0087865A3 (en)	1984-03-07	Pharmaceutical composition
AU2861389A (en)	1989-07-20	Disubstituted pyridines
AU3660284A (en)	1985-06-13	(-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
DE3165050D1 (en)	1984-08-30	Salt of furosemide or piretanide as acid component and penbutolol as base component and pharmaceutical composition containing both of the said components
FI851365A0 (fi)	1985-04-04	Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
NO863867D0 (no)	1986-09-29	Behandling av vandige systemer med synergistiske algicidpreparater.
BE789804A (fr)	1973-04-06	Aminoplaste destine au revetement de materiaux a base de bois et de stratifies ainsi que procede de preparation de cet aminoplaste
FI890864A0 (fi)	1989-02-23	Anvaendning av 1,4-dihydropyridinderivat.
PL264165A2 (en)	1988-07-07	Fungicide in particular for protection of timber
DE3684756D1 (de)	1992-05-14	Durch (omega-amino)-alkanolgruppen substituierte aromatische derivate mit antimikrobenwirkung und diese enthaltende zusammensetzungen.
IL79207A0 (en)	1986-09-30	Pharmaceutical compositions containing terguide
IT1204069B (it)	1989-03-01	Utilizzazione della forma farmaceutica per uso orale di sali ferrosi impiegabili in terapia nelle forme di anemia da carenza di ferro
FI822313A7 (fi)	1982-12-31	Analgeettisina ja anti-inflammatorisina aineina käytettäviä trisyklisiä substituoitujen pyrrolihappojen johdanjohdannaisia.
GB1283367A (en)	1972-07-26	Propionic acid derivatives and manufacture thereof